Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome

Dermatomyositis pathophysiology is complex. In recent years, medical research has identified molecules associated with disease activity. Besides providing insights into the driving mechanisms of dermatomyositis, these findings could provide potential biomarkers. Activity markers can be used to monitor disease activity in clinical trials and may also be useful in daily practice. This article reviews molecules that could be used as biomarkers for diagnosis and monitoring dermatomyositis disease activity.

Domains

Life Sciences [q-bio] Human health and pathology Dermatology Life Sciences [q-bio] Immunology

Fichier principal

Cassius_et_al_JIR2019.pdf (2.4 Mo)

Origin : Publication funded by an institution

Hélène Le Buanec : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02392157

Submitted on : Tuesday, December 3, 2019-7:54:52 PM

Last modification on : Wednesday, December 1, 2021-1:40:02 PM

Long-term archiving on: Wednesday, March 4, 2020-9:22:11 PM

Dates and versions

inserm-02392157 , version 1 (03-12-2019)

Identifiers

HAL Id : inserm-02392157 , version 1
DOI : 10.1155/2019/9141420
PUBMED : 30766892
PUBMEDCENTRAL : PMC6350546

Cite

Charles Cassius, Hélène Le Buanec, Jean-David Bouaziz, Reyhan Amode. Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome. Journal of Immunology Research, 2019, 2019, pp.9141420. ⟨10.1155/2019/9141420⟩. ⟨inserm-02392157⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-PARIS7 USPC UNIV-PARIS UP-SANTE

54 View

169 Download